Dr Ana Levi

Postdoctoral Researcher
Research Focus

In many tumors, PI3K inhibitors are ineffective, in part due to the adaptive kinome rewiring and compensatory activation of bypass signaling pathways in response to PI3K inhibition. My focus is on investigating the epigenetic regulation of the PI3K pathway and identifying an effective combination therapy that will disable compensatory bypass routes, overcoming drug resistance.

Professor Pedro R. Cutillas

Barts Cancer Institute,
Queen Mary University of London,
Charterhouse Square,
London EC1M 6BQ

Email address: bci-admin@qmul.ac.uk
Telephone: +44 20 7882 5555

Upcoming Events

© 2013 ~ 2022 Cancer Research UK Barts Centre